{"authors": [["Yapijakis", "Christos", "C", "Department of Oral and Maxillofacial Surgery, School of Medicine, University of Athens, Attikon Hospital, Athens, Greece. cyapi@med.uoa.gr."]], "date": null, "id": "28971443", "text": "Cerebral venous thrombosis (CVT) is a severe multifactorial condition with various clinical manifestations that may include headache, papilledema, seizures, focal deficits, coma and death. The mortality rate of untreated CVT is up to 50%, but it drops to 10% when CVT is properly treated. Prevention of CVT is feasible through healthy lifestyle, genetic counseling, molecular genetic analysis for common thrombophilia-related mutations, and prophylactic anticoagulative medication.", "doi": "10.1007/978-3-319-57379-3_2", "title": "Cerebral Thrombosis: A Neurogenetic Approach.", "journal": ["Advances in experimental medicine and biology", "Adv. Exp. Med. Biol."]}